Drugs / benzylpenicilloate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01818336 | Dec 2012 → Jun 2013 | IgE responsiveness, atopic | AllerQuest LLC | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | benzylpenicilloate | “benzylpenicilloate” NCT01818336 ↗ |